1055544

Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany — FEI 2211084

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 30, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Whippany, NJ (United States)